Protagonist Stock Based Compensation from 2010 to 2025

PTGX Stock

USD 49.44 0.12 0.24%

Protagonist Therapeutics Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2015-03-31

Previous Quarter

10.2 M

Current Value

9.1 M

Quarterly Volatility

3.1 M

Yuan Drop

Covid

Check Protagonist Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protagonist Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 M, Interest Expense of 4.1 M or Selling General Administrative of 45.6 M, as well as many indicators such as Price To Sales Ratio of 5.2, Dividend Yield of 0.0 or PTB Ratio of 3.7. Protagonist financial statements analysis is a perfect complement when working with Protagonist Therapeutics Valuation or Volatility modules.

Check out the analysis of Protagonist Therapeutics Correlation against competitors.

For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.

Latest Protagonist Therapeutics' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Protagonist Therapeutics over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Protagonist Therapeutics' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Protagonist Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Protagonist Stock Based Compensation Regression Statistics

	Arithmetic Mean	11,045,419
	Geometric Mean	1,531,752
	Coefficient Of Variation	126.50
	Mean Deviation	11,456,076
	Median	6,919,000
	Standard Deviation	13,972,199
	Sample Variance	195.2T
	Range	39.4M
	R-Value	0.90
	Mean Square Error	40.4T
	R-Squared	0.81
	Slope	2,636,060
	Total Sum of Squares	2928.3T

Protagonist Stock Based Compensation History

	2025	39.4 M
	2024	37.6 M
	2023	29.3 M
	2022	24.2 M
	2021	16.4 M
	2020	7.9 M
	2019	8.4 M

Other Fundumenentals of Protagonist Therapeutics

Stock Based Compensation To Revenue

Protagonist Therapeutics Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Long Term Investments	Total Current Assets	Common Stock	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Capital Surpluse	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Short Term Debt
Total Assets		0.58	0.71	-0.61	-0.69	0.28	0.83	0.98	0.18	0.82	0.99	0.13	0.31	0.76	0.58	0.91	-0.55	0.97	0.86	0.03
Total Stockholder Equity	0.58		-0.05	-0.04	-0.07	-0.28	0.74	0.48	-0.36	0.83	0.51	0.05	-0.21	0.16	-0.08	0.27	0.03	0.71	0.48	-0.72
Net Tangible Assets	0.71	-0.05		-0.86	-0.84	0.46	0.45	0.77	0.34	0.21	0.78	0.05	0.44	0.75	0.85	0.88	-0.77	0.57	0.77	0.56
Net Debt	-0.61	-0.04	-0.86		0.88	-0.38	-0.49	-0.61	-0.35	-0.11	-0.69	-0.19	-0.2	-0.65	-0.72	-0.82	0.86	-0.49	-0.63	-0.43
Retained Earnings	-0.69	-0.07	-0.84	0.88		-0.37	-0.54	-0.72	-0.53	-0.21	-0.76	-0.18	-0.42	-0.81	-0.69	-0.92	0.84	-0.58	-0.71	-0.51
Accounts Payable	0.28	-0.28	0.46	-0.38	-0.37		0.27	0.3	0.42	0.0	0.31	0.1	0.26	0.63	0.6	0.4	-0.48	0.11	0.11	0.33
Net Receivables	0.83	0.74	0.45	-0.49	-0.54	0.27		0.77	-0.1	0.71	0.81	0.1	0.27	0.67	0.52	0.69	-0.34	0.78	0.66	-0.38
Short Term Investments	0.98	0.48	0.77	-0.61	-0.72	0.3	0.77		0.18	0.74	0.99	0.1	0.42	0.81	0.61	0.92	-0.57	0.93	0.87	0.14
Total Liab	0.18	-0.36	0.34	-0.35	-0.53	0.42	-0.1	0.18		-0.01	0.2	0.1	0.08	0.35	0.3	0.43	-0.47	0.11	0.14	0.68
Long Term Investments	0.82	0.83	0.21	-0.11	-0.21	0.0	0.71	0.74	-0.01		0.74	0.08	0.01	0.39	0.14	0.53	-0.12	0.89	0.62	-0.37
Total Current Assets	0.99	0.51	0.78	-0.69	-0.76	0.31	0.81	0.99	0.2	0.74		0.14	0.35	0.8	0.63	0.95	-0.62	0.94	0.87	0.11
Common Stock	0.13	0.05	0.05	-0.19	-0.18	0.1	0.1	0.1	0.1	0.08	0.14		0.15	0.35	-0.2	0.15	-0.19	0.15	0.17	0.11
Property Plant Equipment	0.31	-0.21	0.44	-0.2	-0.42	0.26	0.27	0.42	0.08	0.01	0.35	0.15		0.55	0.45	0.42	-0.14	0.16	0.23	0.36
Long Term Debt	0.76	0.16	0.75	-0.65	-0.81	0.63	0.67	0.81	0.35	0.39	0.8	0.35	0.55		0.62	0.86	-0.71	0.66	0.7	0.33
Long Term Debt Total	0.58	-0.08	0.85	-0.72	-0.69	0.6	0.52	0.61	0.3	0.14	0.63	-0.2	0.45	0.62		0.72	-0.53	0.37	0.54	0.34
Capital Surpluse	0.91	0.27	0.88	-0.82	-0.92	0.4	0.69	0.92	0.43	0.53	0.95	0.15	0.42	0.86	0.72		-0.78	0.82	0.84	0.38
Current Deferred Revenue	-0.55	0.03	-0.77	0.86	0.84	-0.48	-0.34	-0.57	-0.47	-0.12	-0.62	-0.19	-0.14	-0.71	-0.53	-0.78		-0.49	-0.58	-0.57
Net Invested Capital	0.97	0.71	0.57	-0.49	-0.58	0.11	0.78	0.93	0.11	0.89	0.94	0.15	0.16	0.66	0.37	0.82	-0.49		0.85	-0.07
Net Working Capital	0.86	0.48	0.77	-0.63	-0.71	0.11	0.66	0.87	0.14	0.62	0.87	0.17	0.23	0.7	0.54	0.84	-0.58	0.85		0.14
Short Term Debt	0.03	-0.72	0.56	-0.43	-0.51	0.33	-0.38	0.14	0.68	-0.37	0.11	0.11	0.36	0.33	0.34	0.38	-0.57	-0.07	0.14

Click cells to compare fundamentals

About Protagonist Therapeutics Financial Statements

Protagonist Therapeutics investors use historical fundamental indicators, such as Protagonist Therapeutics' Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Protagonist Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	37.6 M	39.4 M
Stock Based Compensation To Revenue	0.09	0.08

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Protagonist Stock Analysis

When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Protagonist Stock Based Compensation from 2010 to 2025

Latest Protagonist Therapeutics' Stock Based Compensation Growth Pattern

Protagonist Stock Based Compensation Regression Statistics

Protagonist Stock Based Compensation History

Other Fundumenentals of Protagonist Therapeutics

Protagonist Therapeutics Stock Based Compensation component correlations

About Protagonist Therapeutics Financial Statements

Also Currently Popular

Additional Tools for Protagonist Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY